These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29908880)
21. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies. Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564 [TBL] [Abstract][Full Text] [Related]
22. Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development. Wright CB; Becker SM; Low LA; Tagle DA; Sieving PA J Ocul Pharmacol Ther; 2020; 36(1):25-29. PubMed ID: 31166829 [TBL] [Abstract][Full Text] [Related]
23. 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications. Lauschke VM; Shafagh RZ; Hendriks DFG; Ingelman-Sundberg M Biotechnol J; 2019 Jul; 14(7):e1800347. PubMed ID: 30957976 [TBL] [Abstract][Full Text] [Related]
24. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S Virol J; 2016 Apr; 13():59. PubMed ID: 27044429 [TBL] [Abstract][Full Text] [Related]
25. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. Nagamoto Y; Takayama K; Ohashi K; Okamoto R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H J Hepatol; 2016 May; 64(5):1068-1075. PubMed ID: 26778754 [TBL] [Abstract][Full Text] [Related]
26. Organs-on-a-Chip. Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363 [TBL] [Abstract][Full Text] [Related]
28. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems. Hughes DJ; Kostrzewski T; Sceats EL Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617 [TBL] [Abstract][Full Text] [Related]
29. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing. Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390 [TBL] [Abstract][Full Text] [Related]
30. Three-dimensional hydrogel culture conditions promote the differentiation of human induced pluripotent stem cells into hepatocytes. Luo Y; Lou C; Zhang S; Zhu Z; Xing Q; Wang P; Liu T; Liu H; Li C; Shi W; Du Z; Gao Y Cytotherapy; 2018 Jan; 20(1):95-107. PubMed ID: 28969895 [TBL] [Abstract][Full Text] [Related]
31. A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditions. Tan K; Keegan P; Rogers M; Lu M; Gosset JR; Charest J; Bale SS Lab Chip; 2019 Apr; 19(9):1556-1566. PubMed ID: 30855604 [TBL] [Abstract][Full Text] [Related]
32. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells. Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015 [TBL] [Abstract][Full Text] [Related]
33. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application]. Cao YY; Zeng X Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367 [TBL] [Abstract][Full Text] [Related]
34. Three-dimensional cultured liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells. Kamei KI; Yoshioka M; Terada S; Tokunaga Y; Chen Y Biomed Microdevices; 2019 Jul; 21(3):73. PubMed ID: 31304567 [TBL] [Abstract][Full Text] [Related]
35. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity. Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783 [TBL] [Abstract][Full Text] [Related]
36. Construction of pancreas-muscle-liver microphysiological system (MPS) for reproducing glucose metabolism. Lee DW; Lee SH; Choi N; Sung JH Biotechnol Bioeng; 2019 Dec; 116(12):3433-3445. PubMed ID: 31429925 [TBL] [Abstract][Full Text] [Related]
37. Human iPSC-based cardiac microphysiological system for drug screening applications. Mathur A; Loskill P; Shao K; Huebsch N; Hong S; Marcus SG; Marks N; Mandegar M; Conklin BR; Lee LP; Healy KE Sci Rep; 2015 Mar; 5():8883. PubMed ID: 25748532 [TBL] [Abstract][Full Text] [Related]
38. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. Soto-Gutierrez A; Gough A; Vernetti LA; Taylor DL; Monga SP Exp Biol Med (Maywood); 2017 Oct; 242(16):1605-1616. PubMed ID: 28467181 [TBL] [Abstract][Full Text] [Related]
39. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells. Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008 [TBL] [Abstract][Full Text] [Related]
40. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan]. Kimura H Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]